We are live on ! Find out more
AONC

American Oncology Network, Inc. Class A Common Stock

Delisted

AONC was delisted on the 7th of June, 2024.

49 hedge funds and large institutions have $220M invested in American Oncology Network, Inc. Class A Common Stock in 2021 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 9 increasing their positions, 5 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,100% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 1

80% more repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 5

64% more capital invested

Capital invested by funds: $134M → $220M (+$85.7M)

29% more funds holding

Funds holding: 3849 (+11)

Holders
49
Holders Change
+11
Holders Change %
+28.95%
% of All Funds
0.86%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
12
Increased
9
Reduced
5
Closed
1
Calls
$166K
Puts
Net Calls
+$166K
Net Calls Change
+$166K
Name Holding Trade Value Shares
Change
Change in
Stake
Blackstone Inc
26
Blackstone Inc
New York
$2.42M
DCM
27
Dupont Capital Management
Delaware
$2.42M
Capstone Investment Advisors
28
Capstone Investment Advisors
New York
$1.94M
CCA
29
Castle Creek Arbitrage
Colorado
$1.94M
PMAM
30
Picton Mahoney Asset Management
Ontario, Canada
$1.94M
PAMP
31
Polar Asset Management Partners
Ontario, Canada
$1.94M
VI
32
Vestcor Inc
New Brunswick, Canada
$1.94M
WA
33
Whitebox Advisors
Minnesota
$1.92M -$15.5K -1,600 -0.8%
AA
34
AQR Arbitrage
Connecticut
$1.67M +$501K +51,630 +43%
SCC
35
Spring Creek Capital
Kansas
$1.55M
PCM
36
Prelude Capital Management
New York
$1.51M +$26.7K +2,750 +2%
CCM
37
Context Capital Management
California
$1.45M +$1.45M +149,800 New
Verition Fund Management
38
Verition Fund Management
Connecticut
$1.23M -$1.23M -126,464 -50%
CCM
39
CAAS Capital Management
New York
$1.19M +$1.19M +122,700 New
AA
40
Ancora Advisors
Ohio
$1.15M +$10.7K +1,100 +0.9%
MP
41
Mangrove Partners
Connecticut
$970K
OCAM
42
Owl Creek Asset Management
New York
$950K
PP
43
Paloma Partners
Connecticut
$664K +$663K +68,418 New
Susquehanna International Group
44
Susquehanna International Group
Pennsylvania
$496K
Qube Research & Technologies (QRT)
45
Qube Research & Technologies (QRT)
United Kingdom
$215K
AC
46
Antara Capital
New York
$187K
PAM
47
Panagora Asset Management
Massachusetts
$134K +$134K +13,776 New
TRCT
48
Tower Research Capital (TRC)
New York
$7K +$5.94K +613 +613%
Morgan Stanley
49
Morgan Stanley
New York
$2K +$1.52K +157 New
SM
50
Senvest Management
New York
-$4.87M -500,000 Closed

AONC Hedge Fund Activity: Q3 2021 in Review

49 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in American Oncology Network, Inc. Class A Common Stock (AONC) for Q3 2021, worth a combined $220M — up 64% from $134M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new AONC positions and 1 closed out — a net gain of 11 holders — while 9 added to existing stakes and 5 trimmed.

The largest buyer was Glazer Capital LLC, opening a new position worth an estimated $27.3M. The largest seller was Weiss Asset Management, cutting an estimated $11.5M.

  • 49 institutional investors held American Oncology Network, Inc. Class A Common Stock (AONC) as of Q3 2021, up from 38 in Q2 2021.
  • Funds reported $220M of American Oncology Network, Inc. Class A Common Stock stock for Q3 2021, up 64% quarter-over-quarter.
  • 12 funds opened new American Oncology Network, Inc. Class A Common Stock positions in Q3 2021 and 1 closed out, a net change of +11 holders.
  • The largest American Oncology Network, Inc. Class A Common Stock buyer in Q3 2021 was Glazer Capital LLC, an estimated $27.3M added.
  • The largest American Oncology Network, Inc. Class A Common Stock seller in Q3 2021 was Weiss Asset Management, an estimated $11.5M sold.

Based on aggregated 13F filings for Q3 2021.